Our ex vivo data thus support findings that differences in the tau phosphorylation sites are indeed associated with the severity of neuronal cytopathology in AD and it confirms the assumption that an early hyperphosphorylation of tau at specific epitopes may lead to conformational alterations in the pathological cascade (Augustinack et al., 2002). The gene discussed is MAPT; the disease is Alzheimer disease.